Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection
Open Access
- 20 June 2025
- journal article
- research article
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-13
Abstract
Background The ongoing evolution of SARS-CoV-2, particularly through the emergence of new variants, continues to challenge our understanding of immune protection. While antibody levels correlate with protection against earlier variants such as Alpha and Delta, their relationship with Omicron sub-variants remains unclear. Methods To investigate the role of antibody levels and neutralizing activity in preventing breakthrough infections, we analyzed longitudinal SARS-CoV-2 humoral responses and neutralizing activity against the ancestral virus and major emerging variants in a well-characterized cohort of healthcare workers in Spain (N = 405). Results We find that antibody levels and neutralization titers are key indicators of protection against SARS-CoV-2, including the more evasive BQ.1 and XBB Omicron variants. Higher IgG and IgA levels are associated with protection over three 6-month follow-up periods sequentially dominated by BA.1, BA.2, BA.5, BQ.1, and XBB Omicron sub-variants, although the strength of the association between antibody levels and protection declines over time. Conclusions Our findings demonstrate that binding antibody levels and neutralizing responses are valid correlates of protection against more evasive BQ.1 and XBB Omicron variants, although the strength of this association diminishes over time. Additionally, our results underscore the importance of continuous monitoring and updating vaccination strategies to maintain effective protection against emerging SARS-CoV-2 variants.Keywords
This publication has 64 references indexed in Scilit:
- Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infectionsJournal of Infection, 2025
- SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phaseImmunity, 2024
- SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infectioniScience, 2023
- Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in IsraelJAMA Network Open, 2023
- Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patientsHeliyon, 2022
- Omicron neutralizing antibody response following booster vaccination compared with breakthrough infectionMed, 2022
- Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variantsCell, 2022
- Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workersEBioMedicine, 2022
- Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studiesTranslational Research, 2021
- Association of Age With SARS-CoV-2 Antibody ResponseJAMA Network Open, 2021